General Updates

Remus Pharmaceuticals has announced a board meeting to appoint Sharp & Tannan Associates as internal auditor for FY 2025-26. The firm’s expertise in risk-based auditing and automation via robotics process automation aims to boost audit quality and operational efficiency, supporting stronger internal controls and process optimization.